ArticleImmunity, inflammation and disease2023

Case report: Successful treatment of anti-MDA5-positive to negative dermatomyositis-associated interstitial lung disease with the JAK inhibitor tofacitinib.

Zong Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.